SCHEMBL18106907

SCHEMBL18106907

Fc1ccc(C2CC2)cc1.O=C(O)Nc1nc2ccccc2[nH]1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 12/20 0.60
RAB9A P51151 11/20 0.60
SMN1; SMN2 Q16637 7/20 0.60
PKM P14618 3/20 0.60
TP53 P04637 2/20 0.60
HSD17B10 Q99714 2/20 0.60
KDM4E B2RXH2 1/20 0.60
STAT1 P42224 1/20 0.55
POLB P06746 2/20 0.54
TDP1 Q9NUW8 1/20 0.54
CYP1A2 P05177 1/20 0.53
MAOB P27338 1/20 0.52
ADORA2A P29274 1/20 0.52
LMNA P02545 2/20 0.51
CYP3A4 P08684 1/20 0.51
GAA P10253 1/20 0.51
MTOR P42345 1/20 0.50
MEN1 O00255 1/20 0.50
CASP3 P42574 1/20 0.50
KMT2A Q03164 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18106906 0.91 SMN1; SMN2 (0.63) NPC1RAB9ASMN1; SMN2PKMHSD17B10
SCHEMBL18106896 0.87 NPC1 (0.60) NPC1RAB9ASMN1; SMN2PKMTP53
SCHEMBL204726 0.82 NPC1 (0.73) NPC1RAB9ASMN1; SMN2PKMTP53
SCHEMBL18106895 0.81 LPAR2 (0.67) NPC1RAB9ASMN1; SMN2PKMPOLB
SCHEMBL18106909 0.81 RAB9A (0.60) NPC1RAB9ASMN1; SMN2PKMHSD17B10
SCHEMBL18106890 0.79 LPAR2 (0.64) NPC1RAB9ASMN1; SMN2PKMHSD17B10
SCHEMBL18106887 0.78 NPC1 (0.51) NPC1RAB9ASMN1; SMN2PKMTP53
SCHEMBL15944966 0.78 LPAR2 (0.68) NPC1RAB9ASMN1; SMN2PKMTP53
SCHEMBL18106898 0.78 LPAR2 (0.66) NPC1RAB9ASMN1; SMN2KDM4EPOLB
SCHEMBL18106905 0.77 LPAR2 (0.68) SMN1; SMN2MTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2742029-B1 N-(BENZIMIMDAZOL-2-YL)-CYCLOPROPANE CARBOXAMIDES AS LYSOPHOSPHATIDIC ACID ANTAGONISTS MERCK PATENT GMBH (DE) 2016-10-05 EP claimed